TrialCancer chemotherapy and pharmacology2026

Pharmacokinetic and pharmacodynamic sub-study of trans-arterial vs. intravenous gemcitabine in the TIGeR-PaC phase 3 clinical trial.

Paula M Novelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.